神経調節装置の市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業別予測、2024～2031年

神経調節装置の世界市場規模は、2022年に51億3,000万米ドルと評価され、2023年の55億8,000万米ドルから2031年には108億7,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは8.7％で成長する見通しです。

神経調節装置市場は、慢性疾患の有病率の増加とこれらの疾患に対する医薬品治療の限界により急速に拡大しています。神経調節技術の進歩は、ヒトの神経の機能特性と電気刺激の効果に関する広範な調査によって推進されてきました。疼痛管理に対する脊髄刺激やてんかんに対する迷走神経刺激など、革新的な治療が普及しつつあり、標的治療の進化を浮き彫りにしています。神経変性疾患に対する認識の高まりと、神経調節アプリケーションの開発進展は、主要な成長促進要因です。しかし、運用コストの高さや熟練労働者の不足といった課題は、予測期間中の市場拡大を阻害する可能性があり、こうしたハードルに対処するための戦略的アプローチが必要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• 特許分析
• ケーススタディ

神経調節装置市場規模：製品別

• 市場概要
• 脊髄刺激装置
• 脳深部刺激装置
• 仙骨神経刺激装置
• 迷走神経刺激装置
• 胃電気刺激
• その他

神経調節装置市場規模：用途別

• 市場概要
• パーキンソン病
• 慢性疼痛
• てんかん
• 片頭痛
• 尿失禁および便失禁
• 震え
• うつ
• その他

神経調節装置市場規模：最終用途別

• 市場概要
• 病院および外来手術センター（ASC）
• クリニックと理学療法センター
• その他

神経調節装置市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Medtronic
• Synapse Biomedical
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• Nevro Corp.
• NeuroSigma Inc.
• NeuroPace Inc.
• Cyberonics Inc.
• NDI Medical LLC
• NeuroMetrix Inc.
• NeuroVista Corporation
• Neuronetics Inc.
• BioControl Medical
• SPR Therapeutics
• MicroTransponder Inc.
• Soterix Medical Inc.
• BrainsWay Ltd.
• Saluda Medical Pty Ltd

結論と推奨事項

Global Neuromodulation Devices Market size was valued at USD 5.13 billion in 2022 and is poised to grow from USD 5.58 billion in 2023 to USD 10.87 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The neurostimulation market is expanding rapidly due to the increasing prevalence of chronic conditions and the limitations of pharmaceutical treatments for these diseases. Advances in neurostimulation techniques have been driven by extensive research into the functional properties of human nerves and the effects of electrical stimulation. Innovative treatments, such as spinal cord stimulation for pain management and vagus nerve stimulation for epilepsy, are gaining traction, highlighting the evolution of targeted therapies. The surge in awareness of neurodegenerative diseases and ongoing developments in neuromodulation applications are key growth drivers. However, challenges such as high operational costs and a shortage of skilled workforce may impede market expansion during the forecast period, necessitating strategic approaches to address these hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuromodulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuromodulation Devices Market Segmental Analysis

Global Neuromodulation Devices Market is segmented by Product, Application, End-use, and region. Based on Product, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Gastric Electrical Stimulation, Others. Based on Application, the market is segmented into Parkinson's Disease, Chronic Pain, Epilepsy, Migraine, Urinary & Faecal Incontinence, Tremor, Depression, Others. Based on End-use, the market is segmented into Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuromodulation Devices Market

The global neuromodulation devices market is influenced by several driving factors. A significant contributor to the market's growth is the rising prevalence of health concerns among diverse populations. Neuromodulation devices have gained popularity as effective solutions for managing chronic pain, including conditions such as shoulder pain, headaches, and brain injuries, showcasing their remarkable ability to provide relief across a spectrum of ailments. Furthermore, these devices are increasingly utilized for treating mental health issues, digestive disorders, and sleep-related problems. Consequently, the expanding adoption of neuromodulation technology for addressing a wide range of health conditions is significantly propelling the market forward.

Restraints in the Global Neuromodulation Devices Market

The global neuromodulation devices market faces significant obstacles stemming from several factors. Primarily, the substantial capital investment required poses a considerable barrier to entry, making it difficult for emerging players to establish themselves in the industry. Additionally, the high production costs associated with manufacturing neuromodulation devices further exacerbate this challenge, restricting market growth. Furthermore, the market is impeded by a shortage of skilled professionals, as effective utilization of these devices necessitates expertise and specialized training. This lack of qualified personnel hampers the broader adoption and implementation of neuromodulation therapies, ultimately constraining market expansion.

Market Trends of the Global Neuromodulation Devices Market

The Global Neuromodulation Devices market is experiencing significant growth, driven by an increasing number of patients with chronic conditions such as back pain, depression, epilepsy, and sleep apnea exhibiting resistance to traditional drug therapies. This shift towards neurostimulation methods reflects a proactive response from healthcare practitioners who are seeking more effective solutions for slow-progressing treatments and inadequate outcomes. As the demand for alternative management strategies grows, neuromodulation devices are being increasingly recognized for their potential to enhance patient quality of life, thus propel market expansion, ensuring a promising future for innovative therapeutic approaches in chronic disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Neuromodulation Devices Market Size by Product & CAGR (2024-2031)

• Market Overview
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electrical Stimulation
• Others

Global Neuromodulation Devices Market Size by Application & CAGR (2024-2031)

• Market Overview
• Parkinson's Disease
• Chronic Pain
• Epilepsy
• Migraine
• Urinary & Faecal Incontinence
• Tremor
• Depression
• Others

Global Neuromodulation Devices Market Size by End-use & CAGR (2024-2031)

• Market Overview
• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others

Global Neuromodulation Devices Market Size & CAGR (2024-2031)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NDI Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroMetrix Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroVista Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioControl Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainsWay Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation